The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on meeting demand for the drug in the world's most populous country.

Empower Pharmacy By Jishnu Nair – Reporter, Houston Business Journal Jun 12, 2025 Preview this article 1 min ...

Eli Lilly and Co. is considering Houston as a location for one of its four planned new U.S. manufacturing sites, with the Texas city potentially landing a $5.9 billion facility that could employ ...

Eli Lilly is considering a 236-acre tract of McCord Development’s Generation Park for the manufacturing plant, which would have a direct economic impact worth $2.5B over 10 years, according to ...

Pharma giant Eli Lilly may plant a $5.9 billion manufacturing facility in Houston’s Generation Park, bringing serious biotech swagger to the region. The proposed project would create 600 permanent ...

Pharma giant Eli Lilly eyes Houston for $5.9B biomanufacturing plant that could bring over 2,000 jobs By Marissa Luck, Staff writer Updated May 19, 2025 4:38 p.m.

Houston Business Journal Major pharmaceutical manufacturer considers move into Houston Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.

Eli Lilly is jockeying for a tax break in Texas as it weighs whether to build a $5.9 billion active pharmaceutical ingredient (API) manufacturing facility in Houston, according to a recent filing ...

Eli Lilly is considering purchasing 236 acres at Generation Park, according to filings. Generation Park is a sprawling, 4,300-acre business and lifestyle community located in northeast Houston.